Lsv Asset Management Amneal Pharmaceuticals, Inc. Transaction History

Lsv Asset Management

$41.9 Billion
Q2 2025

A detailed history of Lsv Asset Management transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Lsv Asset Management holds 169,900 shares of AMRX stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

169,900

Previous 169,900 -0.0%

Holding current value

$1.9 Million

Previous $1.42 Million 3.51%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$7.72 - $9.01 $1.31 Million - $1.53 Million	169,900 New	169,900 $1.42 Million
Q2 2024 Aug 06, 2024	SELL	$5.36 - $7.11 $44,488 - $59,013	-8,300 Reduced 0.78%	1,057,300 $6.71 Million
Q1 2024 May 06, 2024	SELL	$5.24 - $6.34 $124,188 - $150,258	-23,700 Reduced 2.18%	1,065,600 $6.46 Million
Q4 2023 Feb 06, 2024	SELL	$3.36 - $6.21 $1.14 Million - $2.11 Million	-340,000 Reduced 23.79%	1,089,300 $6.61 Million
Q3 2023 Nov 03, 2023	BUY	$2.76 - $4.59 $375,636 - $624,699	136,100 Added 10.52%	1,429,300 $6.03 Million
Q2 2023 Aug 02, 2023	SELL	$1.33 - $3.1 $138,320 - $322,400	-104,000 Reduced 7.44%	1,293,200 $4.01 Million
Q3 2022 Nov 07, 2022	SELL	$2.02 - $3.62 $272,700 - $488,700	-135,000 Reduced 8.81%	1,397,200 $2.82 Million
Q2 2022 Aug 10, 2022	SELL	$3.01 - $4.46 $60,199 - $89,200	-20,000 Reduced 1.29%	1,532,200 $4.87 Million
Q1 2022 May 12, 2022	SELL	$3.9 - $4.89 $74,100 - $92,910	-19,000 Reduced 1.21%	1,552,200 $6.47 Million
Q4 2021 Jan 28, 2022	BUY	$3.95 - $5.85 $101,120 - $149,760	25,600 Added 1.66%	1,571,200 $7.53 Million
Q2 2021 Aug 04, 2021	BUY	$5.12 - $6.82 $1.44 Million - $1.92 Million	282,000 Added 22.32%	1,545,600 $7.91 Million
Q1 2021 Apr 30, 2021	BUY	$4.74 - $7.38 $814,332 - $1.27 Million	171,800 Added 15.74%	1,263,600 $8.5 Million
Q4 2020 Feb 08, 2021	SELL	$3.95 - $5.42 $84,925 - $116,530	-21,500 Reduced 1.93%	1,091,800 $4.99 Million
Q3 2020 Oct 23, 2020	BUY	$3.54 - $5.27 $628,350 - $935,424	177,500 Added 18.97%	1,113,300 $4.32 Million
Q2 2020 Aug 05, 2020	BUY	$2.87 - $5.46 $1.66 Million - $3.17 Million	580,000 Added 163.01%	935,800 $4.45 Million
Q1 2020 May 07, 2020	SELL	$2.46 - $5.35 $29,028 - $63,129	-11,800 Reduced 3.21%	355,800 $1.24 Million
Q3 2019 Nov 07, 2019	BUY	$2.29 - $7.1 $841,804 - $2.61 Million	367,600 New	367,600 $1.07 Million

Others Institutions Holding AMRX

# of Institutions

256

Shares Held

146M

Call Options Held

194K

Put Options Held

49.3K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.7B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account

Lsv Asset Management Amneal Pharmaceuticals, Inc. Transaction History